Clinical Trials
What for
Affidea’s internationally awarded clinical excellence, with certifications and accreditations across all medical specialties, combined with its broad geographical reach, makes the Affidea Group the preferred healthcare partner for leading pharmaceutical companies, medical institutions, AI organizations, and medical device manufacturers – both in Greece and internationally.
Our extensive pan-European network spans 15 countries and includes over 420 medical facilities, with 23 specialized and integrated Clinical Research Centers operating in 7 of these countries. This network is organically integrated into Affidea’s existing healthcare services, allowing us to offer Clinical Research as a Care Option – a natural extension of daily clinical practice.
In Greece, the Clinical Research Department has been active since 2014 and manages dozens of ongoing studies. Our research supports fields such as – among others – Alzheimer’s disease, melanoma, lymphomas, multiple myeloma, multiple sclerosis, spondyloarthritis, and malignancies including breast, lung, prostate, and colorectal cancer.
At Affidea, we are fully committed to improving clinical outcomes for the benefit of patients. We offer our technological superiority, scientific expertise, and highly trained physicians to support researchers in developing more personalized and effective therapies. Together, we shape the future of medical research – with a vision to save more lives.
What for - Clinical Trials
Affidea’s internationally awarded clinical excellence, with certifications and accreditations across all medical specialties, combined with its broad geographical reach, makes the Affidea Group the preferred healthcare partner for leading pharmaceutical companies, medical institutions, AI organizations, and medical device manufacturers – both in Greece and internationally.
Our extensive pan-European network spans 15 countries and includes over 420 medical facilities, with 23 specialized and integrated Clinical Research Centers operating in 7 of these countries. This network is organically integrated into Affidea’s existing healthcare services, allowing us to offer Clinical Research as a Care Option – a natural extension of daily clinical practice.
In Greece, the Clinical Research Department has been active since 2014 and manages dozens of ongoing studies. Our research supports fields such as – among others – Alzheimer’s disease, melanoma, lymphomas, multiple myeloma, multiple sclerosis, spondyloarthritis, and malignancies including breast, lung, prostate, and colorectal cancer.
At Affidea, we are fully committed to improving clinical outcomes for the benefit of patients. We offer our technological superiority, scientific expertise, and highly trained physicians to support researchers in developing more personalized and effective therapies. Together, we shape the future of medical research – with a vision to save more lives.
